Research progress in molecular pathology markers in medulloblastoma.

Zhou, Zixuan; Zhu, Bingxin; Meng, Qingming; Zhang, Tong; Wu, Yihao; Yu, Rutong; Gao, Shangfeng.

Afiliação

Zhou Z; Department of Neurosurgery, Institute of Nervous System Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.
Zhu B; Department of Neurosurgery, Xuzhou Children's Hospital, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.
Meng Q; Department of Neurosurgery, Institute of Nervous System Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.
Zhang T; Department of Neurosurgery, Institute of Nervous System Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.
Wu Y; Department of Neurosurgery, Institute of Nervous System Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.
Yu R; Department of Neurosurgery, Institute of Nervous System Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.
Gao S; Department of Neurosurgery, Xuzhou Children's Hospital, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China.

Explor Target Antitumor Ther ; 4(1): 139-156, 2023.

Article em En | MEDLINE | ID: mdl-36937322